Prevalence and prognostic significance of adrenergic escape during chronic β-blocker therapy in chronic heart failure

被引:10
|
作者
Frankenstein, Lutz [1 ]
Zugck, Christian [1 ]
Schellberg, Dieter [1 ]
Nelles, Manfred [1 ]
Froehlich, Hanna [1 ]
Katus, Hugo [1 ]
Remppis, Andrew [1 ]
机构
[1] Univ Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
Adrenergic escape; beta-Blocker; Chronic heart failure; Prognosis; ANGIOTENSIN-CONVERTING ENZYME; RANDOMIZED INTERVENTION TRIAL; LEFT-VENTRICULAR DYSFUNCTION; ALDOSTERONE ESCAPE; MERIT-HF; DILATED CARDIOMYOPATHY; CLINICAL-OUTCOMES; METOPROLOL; SURVIVAL; PHEOCHROMOCYTOMA;
D O I
10.1093/eurjhf/hfn028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Like aldosterone escape to ACE-inhibitors, adrenergic escape (AE) to beta-blockers appears conceivable in chronic heart failure (CHF), as generalized systemic neurohumoral activation has been described as the pathophysiological basis of this syndrome. The aim of this study was to examine the prevalence and prognostic value of AE with respect to different beta-blocker agents and doses. This was a prospective, observational study of 415 patients with systolic CHF receiving chronic stable beta-blocker therapy. AE was defined by norepinephrine levels above the upper limit of normal. Irrespective of the individual beta-blocker agents used and the dose equivalent taken, the prevalence of AE was 31-39%. Norepinephrine levels neither correlated with heart rate (r = 0.02; 95% CI: -0.08-0.11; P = 0.74) nor were they related to underlying rhythm (P = 0.09) or the individual beta-blocker agent used (P = 0.87). The presence of AE was a strong and independent indicator of mortality (adjusted HR: 1.915; 95% CI: 1.387-2.645; chi(2): 15.60). We verified the presence of AE in CHF patients on chronic stable beta-blocker therapy, irrespective of the individual beta-blocker agent and the dose equivalent. As AE might indicate therapeutic failure, the determination of AE could help to identify those patients with CHF that might benefit from more aggressive treatment modalities. Heart rate, however, is not a surrogate for adrenergic escape.
引用
收藏
页码:178 / 184
页数:7
相关论文
共 50 条
  • [21] PREVALENCE AND PROGNOSTIC RELEVANCE OF IRON DEFICIENCY IN CHRONIC HEART FAILURE
    Amato, L.
    Lisi, F.
    Bellino, M.
    Parisi, G.
    Gioia, M.
    Grande, D.
    Ciccone, M.
    Caldarola, P.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E170 - E170
  • [22] Challenges of beta blocker therapy in chronic heart failure: The story continues
    Lainscak, Mitja
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2008, 7 (03) : 159 - 160
  • [23] β-adrenergic blockade in chronic heart failure
    Bristow, M
    Port, JD
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 1998, 32 : 45 - 55
  • [24] Prognostic significance of heart rate turbulence parameters in patients with chronic heart failure
    De-Chun Yin
    Zhao-Jun Wang
    Shuai Guo
    Hong-Yu Xie
    Lin Sun
    Wei Feng
    Wei Qiu
    Xiu-Fen Qu
    BMC Cardiovascular Disorders, 14
  • [25] Prognostic significance of heart rate turbulence parameters in patients with chronic heart failure
    Yin, De-Chun
    Wang, Zhao-Jun
    Guo, Shuai
    Xie, Hong-Yu
    Sun, Lin
    Feng, Wei
    Qiu, Wei
    Qu, Xiu-Fen
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [26] Safety of Concomitant Angiotensin Receptor Blocker Therapy in Chronic Heart Failure Patients on Conventional Heart Failure Therapy
    Atashband, Armita
    Vemuri, Srinath
    Deswal, Anita
    Aguilar, David
    Ramasubbu, Kumudha
    Pritchett, Allison
    Kar, Biswajit
    Bozkurt, Biykem
    HYPERTENSION, 2009, 54 (04) : E73 - E73
  • [27] Prognostic Value of Emerging Neurohormones in Chronic Heart Failure during Optimization of Heart Failure-Specific Therapy
    Neuhold, Stephanie
    Huelsmann, Martin
    Strunk, Guido
    Struck, Joachim
    Adlbrecht, Christopher
    Gouya, Ghazaleh
    Elhenicky, Marie
    Pacher, Richard
    CLINICAL CHEMISTRY, 2010, 56 (01) : 121 - 126
  • [28] High prevalence of "ACE-escape" in severe chronic heart failure patients
    Van de Wall, RMA
    Smilde, TJ
    Van Veldhuisen, DJ
    Lok, DJ
    Plokker, HWT
    Van Gilst, WH
    Voors, AA
    EUROPEAN HEART JOURNAL, 2004, 25 : 452 - 452
  • [29] Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy
    Tabet, Jean Yves
    Metra, Marco
    Thabut, Gabriel
    Logeart, Damien
    Cohen-Solal, Alain
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (04): : 500 - 503
  • [30] ARRHYTHMIAS IN CHRONIC HEART-FAILURE - PROGNOSTIC-SIGNIFICANCE AND TREATMENT
    KOENIG, A
    CHAUVIN, M
    THEVENIN, D
    BRECHENMACHER, C
    PRESSE MEDICALE, 1991, 20 (20): : 950 - 955